Madrigal Pharmaceuticals madrigalpharma.com


Public list: Pharma Startups (4732) Rare Diseases (230)

Madrigal Pharmaceuticals (Nasdaq: MGDL), formerly Synta Pharmaceuticals, is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. The company's lead candidate, MGL-3196, is a first-in-class, orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) β-sel...Show all

Madrigal Pharmaceuticals (Nasdaq: MGDL), formerly Synta Pharmaceuticals, is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechani...Show all

Company (IPO / Went public)

Phone:

Fax:

200 Barr Harbor Drive
Suite 400
Conshohocken, 19428
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Madrigal Pharmaceuticals $130M Feb 6, 2007

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Madrigal Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of synthesizing thyroid hormone analogs and polymorphs thereof Feb 17, 2016 May 15, 2018 Patent
Targeted therapeutics Sep 15, 2016 May 01, 2018 Patent
Compositions and methods for modulating c-rel-dependent cytokine production Nov 14, 2014 Mar 06, 2018 Patent
Compounds for inflammation and immune-related uses May 03, 2012 Mar 28, 2017 Patent
Targeted therapeutics Oct 09, 2014 Mar 21, 2017 Patent
See all 84 patents